オレキシン受容体タイプ2の世界市場（～2026年）

• 英文タイトル：Global Orexin Receptor Type 2 Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY08422 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料はオレキシン受容体タイプ2のグローバル市場について調査・分析したレポートです。種類別（HTL-6641、MK-8133、Lemborexant、OPN-021、YNT-185、その他）市場規模、用途別（不眠症、ナルコレプシー、睡眠障害、大うつ病性障害）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別オレキシン受容体タイプ2の競争状況、市場シェア ・世界のオレキシン受容体タイプ2市場：種類別市場規模 2015年-2020年（HTL-6641、MK-8133、Lemborexant、OPN-021、YNT-185、その他） ・世界のオレキシン受容体タイプ2市場：種類別市場規模予測 2021年-2026年（HTL-6641、MK-8133、Lemborexant、OPN-021、YNT-185、その他） ・世界のオレキシン受容体タイプ2市場：用途別市場規模 2015年-2020年（不眠症、ナルコレプシー、睡眠障害、大うつ病性障害） ・世界のオレキシン受容体タイプ2市場：用途別市場規模予測 2021年-2026年（不眠症、ナルコレプシー、睡眠障害、大うつ病性障害） ・北米のオレキシン受容体タイプ2市場分析：米国、カナダ ・ヨーロッパのオレキシン受容体タイプ2市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのオレキシン受容体タイプ2市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のオレキシン受容体タイプ2市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのオレキシン受容体タイプ2市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Actelion Pharmaceuticals Ltd、Eisai Co Ltd、Evotec AG、Heptares Therapeutics Ltd、Idorsia Ltd、Johnson & Johnson、Merck & Co Inc、OptiNose US Inc、Yangtze River Pharmaceutical Group ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Market Analysis and Insights: Global Orexin Receptor Type 2 Market
The global Orexin Receptor Type 2 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Orexin Receptor Type 2 Scope and Market Size
Orexin Receptor Type 2 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Orexin Receptor Type 2 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Orexin Receptor Type 2 market is segmented into
HTL-6641
MK-8133
Lemborexant
OPN-021
YNT-185
Others

Segment by Application, the Orexin Receptor Type 2 market is segmented into
Insomnia
Narcolepsy
Sleep Disorders
Major Depressive Disorder

Regional and Country-level Analysis
The Orexin Receptor Type 2 market is analysed and market size information is provided by regions (countries).
The key regions covered in the Orexin Receptor Type 2 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Orexin Receptor Type 2 Market Share Analysis
Orexin Receptor Type 2 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Orexin Receptor Type 2 business, the date to enter into the Orexin Receptor Type 2 market, Orexin Receptor Type 2 product introduction, recent developments, etc.

The major vendors covered:
Actelion Pharmaceuticals Ltd
Eisai Co Ltd
Evotec AG
Heptares Therapeutics Ltd
Idorsia Ltd
Johnson & Johnson
Merck & Co Inc
OptiNose US Inc
Yangtze River Pharmaceutical Group

レポート目次

---

1 Study Coverage
1.1 Orexin Receptor Type 2 Product Introduction
1.2 Market Segments
1.3 Key Orexin Receptor Type 2 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Orexin Receptor Type 2 Market Size Growth Rate by Type
1.4.2 HTL-6641
1.4.3 MK-8133
1.4.4 Lemborexant
1.4.5 OPN-021
1.4.6 YNT-185
1.4.7 Others
1.5 Market by Application
1.5.1 Global Orexin Receptor Type 2 Market Size Growth Rate by Application
1.5.2 Insomnia
1.5.3 Narcolepsy
1.5.4 Sleep Disorders
1.5.5 Major Depressive Disorder
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Orexin Receptor Type 2 Market Size, Estimates and Forecasts
2.1.1 Global Orexin Receptor Type 2 Revenue 2015-2026
2.1.2 Global Orexin Receptor Type 2 Sales 2015-2026
2.2 Global Orexin Receptor Type 2, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Orexin Receptor Type 2 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Orexin Receptor Type 2 Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Orexin Receptor Type 2 Competitor Landscape by Players
3.1 Orexin Receptor Type 2 Sales by Manufacturers
3.1.1 Orexin Receptor Type 2 Sales by Manufacturers (2015-2020)
3.1.2 Orexin Receptor Type 2 Sales Market Share by Manufacturers (2015-2020)
3.2 Orexin Receptor Type 2 Revenue by Manufacturers
3.2.1 Orexin Receptor Type 2 Revenue by Manufacturers (2015-2020)
3.2.2 Orexin Receptor Type 2 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Orexin Receptor Type 2 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Orexin Receptor Type 2 Revenue in 2019
3.2.5 Global Orexin Receptor Type 2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Orexin Receptor Type 2 Price by Manufacturers
3.4 Orexin Receptor Type 2 Manufacturing Base Distribution, Product Types
3.4.1 Orexin Receptor Type 2 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Orexin Receptor Type 2 Product Type
3.4.3 Date of International Manufacturers Enter into Orexin Receptor Type 2 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Orexin Receptor Type 2 Market Size by Type (2015-2020)
4.1.1 Global Orexin Receptor Type 2 Sales by Type (2015-2020)
4.1.2 Global Orexin Receptor Type 2 Revenue by Type (2015-2020)
4.1.3 Orexin Receptor Type 2 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Orexin Receptor Type 2 Market Size Forecast by Type (2021-2026)
4.2.1 Global Orexin Receptor Type 2 Sales Forecast by Type (2021-2026)
4.2.2 Global Orexin Receptor Type 2 Revenue Forecast by Type (2021-2026)
4.2.3 Orexin Receptor Type 2 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Orexin Receptor Type 2 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Orexin Receptor Type 2 Market Size by Application (2015-2020)
5.1.1 Global Orexin Receptor Type 2 Sales by Application (2015-2020)
5.1.2 Global Orexin Receptor Type 2 Revenue by Application (2015-2020)
5.1.3 Orexin Receptor Type 2 Price by Application (2015-2020)
5.2 Orexin Receptor Type 2 Market Size Forecast by Application (2021-2026)
5.2.1 Global Orexin Receptor Type 2 Sales Forecast by Application (2021-2026)
5.2.2 Global Orexin Receptor Type 2 Revenue Forecast by Application (2021-2026)
5.2.3 Global Orexin Receptor Type 2 Price Forecast by Application (2021-2026)

6 North America
6.1 North America Orexin Receptor Type 2 by Country
6.1.1 North America Orexin Receptor Type 2 Sales by Country
6.1.2 North America Orexin Receptor Type 2 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Orexin Receptor Type 2 Market Facts & Figures by Type
6.3 North America Orexin Receptor Type 2 Market Facts & Figures by Application

7 Europe
7.1 Europe Orexin Receptor Type 2 by Country
7.1.1 Europe Orexin Receptor Type 2 Sales by Country
7.1.2 Europe Orexin Receptor Type 2 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Orexin Receptor Type 2 Market Facts & Figures by Type
7.3 Europe Orexin Receptor Type 2 Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Orexin Receptor Type 2 by Region
8.1.1 Asia Pacific Orexin Receptor Type 2 Sales by Region
8.1.2 Asia Pacific Orexin Receptor Type 2 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Orexin Receptor Type 2 Market Facts & Figures by Type
8.3 Asia Pacific Orexin Receptor Type 2 Market Facts & Figures by Application

9 Latin America
9.1 Latin America Orexin Receptor Type 2 by Country
9.1.1 Latin America Orexin Receptor Type 2 Sales by Country
9.1.2 Latin America Orexin Receptor Type 2 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Orexin Receptor Type 2 Market Facts & Figures by Type
9.3 Central & South America Orexin Receptor Type 2 Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Orexin Receptor Type 2 by Country
10.1.1 Middle East and Africa Orexin Receptor Type 2 Sales by Country
10.1.2 Middle East and Africa Orexin Receptor Type 2 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Orexin Receptor Type 2 Market Facts & Figures by Type
10.3 Middle East and Africa Orexin Receptor Type 2 Market Facts & Figures by Application

11 Company Profiles
11.1 Actelion Pharmaceuticals Ltd
11.1.1 Actelion Pharmaceuticals Ltd Corporation Information
11.1.2 Actelion Pharmaceuticals Ltd Description and Business Overview
11.1.3 Actelion Pharmaceuticals Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Actelion Pharmaceuticals Ltd Orexin Receptor Type 2 Products Offered
11.1.5 Actelion Pharmaceuticals Ltd Related Developments
11.2 Eisai Co Ltd
11.2.1 Eisai Co Ltd Corporation Information
11.2.2 Eisai Co Ltd Description and Business Overview
11.2.3 Eisai Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Eisai Co Ltd Orexin Receptor Type 2 Products Offered
11.2.5 Eisai Co Ltd Related Developments
11.3 Evotec AG
11.3.1 Evotec AG Corporation Information
11.3.2 Evotec AG Description and Business Overview
11.3.3 Evotec AG Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Evotec AG Orexin Receptor Type 2 Products Offered
11.3.5 Evotec AG Related Developments
11.4 Heptares Therapeutics Ltd
11.4.1 Heptares Therapeutics Ltd Corporation Information
11.4.2 Heptares Therapeutics Ltd Description and Business Overview
11.4.3 Heptares Therapeutics Ltd Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Heptares Therapeutics Ltd Orexin Receptor Type 2 Products Offered
11.4.5 Heptares Therapeutics Ltd Related Developments
11.5 Idorsia Ltd
11.5.1 Idorsia Ltd Corporation Information
11.5.2 Idorsia Ltd Description and Business Overview
11.5.3 Idorsia Ltd Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Idorsia Ltd Orexin Receptor Type 2 Products Offered
11.5.5 Idorsia Ltd Related Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Corporation Information
11.6.2 Johnson & Johnson Description and Business Overview
11.6.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Johnson & Johnson Orexin Receptor Type 2 Products Offered
11.6.5 Johnson & Johnson Related Developments
11.7 Merck & Co Inc
11.7.1 Merck & Co Inc Corporation Information
11.7.2 Merck & Co Inc Description and Business Overview
11.7.3 Merck & Co Inc Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Merck & Co Inc Orexin Receptor Type 2 Products Offered
11.7.5 Merck & Co Inc Related Developments
11.8 OptiNose US Inc
11.8.1 OptiNose US Inc Corporation Information
11.8.2 OptiNose US Inc Description and Business Overview
11.8.3 OptiNose US Inc Sales, Revenue and Gross Margin (2015-2020)
11.8.4 OptiNose US Inc Orexin Receptor Type 2 Products Offered
11.8.5 OptiNose US Inc Related Developments
11.9 Yangtze River Pharmaceutical Group
11.9.1 Yangtze River Pharmaceutical Group Corporation Information
11.9.2 Yangtze River Pharmaceutical Group Description and Business Overview
11.9.3 Yangtze River Pharmaceutical Group Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Yangtze River Pharmaceutical Group Orexin Receptor Type 2 Products Offered
11.9.5 Yangtze River Pharmaceutical Group Related Developments
11.1 Actelion Pharmaceuticals Ltd
11.1.1 Actelion Pharmaceuticals Ltd Corporation Information
11.1.2 Actelion Pharmaceuticals Ltd Description and Business Overview
11.1.3 Actelion Pharmaceuticals Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Actelion Pharmaceuticals Ltd Orexin Receptor Type 2 Products Offered
11.1.5 Actelion Pharmaceuticals Ltd Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Orexin Receptor Type 2 Market Estimates and Projections by Region
12.1.1 Global Orexin Receptor Type 2 Sales Forecast by Regions 2021-2026
12.1.2 Global Orexin Receptor Type 2 Revenue Forecast by Regions 2021-2026
12.2 North America Orexin Receptor Type 2 Market Size Forecast (2021-2026)
12.2.1 North America: Orexin Receptor Type 2 Sales Forecast (2021-2026)
12.2.2 North America: Orexin Receptor Type 2 Revenue Forecast (2021-2026)
12.2.3 North America: Orexin Receptor Type 2 Market Size Forecast by Country (2021-2026)
12.3 Europe Orexin Receptor Type 2 Market Size Forecast (2021-2026)
12.3.1 Europe: Orexin Receptor Type 2 Sales Forecast (2021-2026)
12.3.2 Europe: Orexin Receptor Type 2 Revenue Forecast (2021-2026)
12.3.3 Europe: Orexin Receptor Type 2 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Orexin Receptor Type 2 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Orexin Receptor Type 2 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Orexin Receptor Type 2 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Orexin Receptor Type 2 Market Size Forecast by Region (2021-2026)
12.5 Latin America Orexin Receptor Type 2 Market Size Forecast (2021-2026)
12.5.1 Latin America: Orexin Receptor Type 2 Sales Forecast (2021-2026)
12.5.2 Latin America: Orexin Receptor Type 2 Revenue Forecast (2021-2026)
12.5.3 Latin America: Orexin Receptor Type 2 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Orexin Receptor Type 2 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Orexin Receptor Type 2 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Orexin Receptor Type 2 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Orexin Receptor Type 2 Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Orexin Receptor Type 2 Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Orexin Receptor Type 2 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Orexin Receptor Type 2 Market Segments
Table 2. Ranking of Global Top Orexin Receptor Type 2 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Orexin Receptor Type 2 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of HTL-6641
Table 5. Major Manufacturers of MK-8133
Table 6. Major Manufacturers of Lemborexant
Table 7. Major Manufacturers of OPN-021
Table 8. Major Manufacturers of YNT-185
Table 9. Major Manufacturers of Others
Table 10. Global Orexin Receptor Type 2 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global Orexin Receptor Type 2 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global Orexin Receptor Type 2 Sales by Regions 2015-2020 (K Pcs)
Table 13. Global Orexin Receptor Type 2 Sales Market Share by Regions (2015-2020)
Table 14. Global Orexin Receptor Type 2 Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Orexin Receptor Type 2 Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Orexin Receptor Type 2 Sales Share by Manufacturers (2015-2020)
Table 17. Global Orexin Receptor Type 2 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Orexin Receptor Type 2 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Orexin Receptor Type 2 as of 2019)
Table 19. Orexin Receptor Type 2 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Orexin Receptor Type 2 Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Orexin Receptor Type 2 Price (2015-2020) (USD/Pcs)
Table 22. Orexin Receptor Type 2 Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Orexin Receptor Type 2 Product Type
Table 24. Date of International Manufacturers Enter into Orexin Receptor Type 2 Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Orexin Receptor Type 2 Sales by Type (2015-2020) (K Pcs)
Table 27. Global Orexin Receptor Type 2 Sales Share by Type (2015-2020)
Table 28. Global Orexin Receptor Type 2 Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Orexin Receptor Type 2 Revenue Share by Type (2015-2020)
Table 30. Orexin Receptor Type 2 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Orexin Receptor Type 2 Sales by Application (2015-2020) (K Pcs)
Table 32. Global Orexin Receptor Type 2 Sales Share by Application (2015-2020)
Table 33. North America Orexin Receptor Type 2 Sales by Country (2015-2020) (K Pcs)
Table 34. North America Orexin Receptor Type 2 Sales Market Share by Country (2015-2020)
Table 35. North America Orexin Receptor Type 2 Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Orexin Receptor Type 2 Revenue Market Share by Country (2015-2020)
Table 37. North America Orexin Receptor Type 2 Sales by Type (2015-2020) (K Pcs)
Table 38. North America Orexin Receptor Type 2 Sales Market Share by Type (2015-2020)
Table 39. North America Orexin Receptor Type 2 Sales by Application (2015-2020) (K Pcs)
Table 40. North America Orexin Receptor Type 2 Sales Market Share by Application (2015-2020)
Table 41. Europe Orexin Receptor Type 2 Sales by Country (2015-2020) (K Pcs)
Table 42. Europe Orexin Receptor Type 2 Sales Market Share by Country (2015-2020)
Table 43. Europe Orexin Receptor Type 2 Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Orexin Receptor Type 2 Revenue Market Share by Country (2015-2020)
Table 45. Europe Orexin Receptor Type 2 Sales by Type (2015-2020) (K Pcs)
Table 46. Europe Orexin Receptor Type 2 Sales Market Share by Type (2015-2020)
Table 47. Europe Orexin Receptor Type 2 Sales by Application (2015-2020) (K Pcs)
Table 48. Europe Orexin Receptor Type 2 Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Orexin Receptor Type 2 Sales by Region (2015-2020) (K Pcs)
Table 50. Asia Pacific Orexin Receptor Type 2 Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Orexin Receptor Type 2 Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Orexin Receptor Type 2 Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Orexin Receptor Type 2 Sales by Type (2015-2020) (K Pcs)
Table 54. Asia Pacific Orexin Receptor Type 2 Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Orexin Receptor Type 2 Sales by Application (2015-2020) (K Pcs)
Table 56. Asia Pacific Orexin Receptor Type 2 Sales Market Share by Application (2015-2020)
Table 57. Latin America Orexin Receptor Type 2 Sales by Country (2015-2020) (K Pcs)
Table 58. Latin America Orexin Receptor Type 2 Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Orexin Receptor Type 2 Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Orexin Receptor Type 2 Revenue Market Share by Country (2015-2020)
Table 61. Latin America Orexin Receptor Type 2 Sales by Type (2015-2020) (K Pcs)
Table 62. Latin America Orexin Receptor Type 2 Sales Market Share by Type (2015-2020)
Table 63. Latin America Orexin Receptor Type 2 Sales by Application (2015-2020) (K Pcs)
Table 64. Latin America Orexin Receptor Type 2 Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Orexin Receptor Type 2 Sales by Country (2015-2020) (K Pcs)
Table 66. Middle East and Africa Orexin Receptor Type 2 Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Orexin Receptor Type 2 Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Orexin Receptor Type 2 Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Orexin Receptor Type 2 Sales by Type (2015-2020) (K Pcs)
Table 70. Middle East and Africa Orexin Receptor Type 2 Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Orexin Receptor Type 2 Sales by Application (2015-2020) (K Pcs)
Table 72. Middle East and Africa Orexin Receptor Type 2 Sales Market Share by Application (2015-2020)
Table 73. Actelion Pharmaceuticals Ltd Corporation Information
Table 74. Actelion Pharmaceuticals Ltd Description and Major Businesses
Table 75. Actelion Pharmaceuticals Ltd Orexin Receptor Type 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. Actelion Pharmaceuticals Ltd Product
Table 77. Actelion Pharmaceuticals Ltd Recent Development
Table 78. Eisai Co Ltd Corporation Information
Table 79. Eisai Co Ltd Description and Major Businesses
Table 80. Eisai Co Ltd Orexin Receptor Type 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Eisai Co Ltd Product
Table 82. Eisai Co Ltd Recent Development
Table 83. Evotec AG Corporation Information
Table 84. Evotec AG Description and Major Businesses
Table 85. Evotec AG Orexin Receptor Type 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Evotec AG Product
Table 87. Evotec AG Recent Development
Table 88. Heptares Therapeutics Ltd Corporation Information
Table 89. Heptares Therapeutics Ltd Description and Major Businesses
Table 90. Heptares Therapeutics Ltd Orexin Receptor Type 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Heptares Therapeutics Ltd Product
Table 92. Heptares Therapeutics Ltd Recent Development
Table 93. Idorsia Ltd Corporation Information
Table 94. Idorsia Ltd Description and Major Businesses
Table 95. Idorsia Ltd Orexin Receptor Type 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. Idorsia Ltd Product
Table 97. Idorsia Ltd Recent Development
Table 98. Johnson & Johnson Corporation Information
Table 99. Johnson & Johnson Description and Major Businesses
Table 100. Johnson & Johnson Orexin Receptor Type 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Johnson & Johnson Product
Table 102. Johnson & Johnson Recent Development
Table 103. Merck & Co Inc Corporation Information
Table 104. Merck & Co Inc Description and Major Businesses
Table 105. Merck & Co Inc Orexin Receptor Type 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. Merck & Co Inc Product
Table 107. Merck & Co Inc Recent Development
Table 108. OptiNose US Inc Corporation Information
Table 109. OptiNose US Inc Description and Major Businesses
Table 110. OptiNose US Inc Orexin Receptor Type 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 111. OptiNose US Inc Product
Table 112. OptiNose US Inc Recent Development
Table 113. Yangtze River Pharmaceutical Group Corporation Information
Table 114. Yangtze River Pharmaceutical Group Description and Major Businesses
Table 115. Yangtze River Pharmaceutical Group Orexin Receptor Type 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 116. Yangtze River Pharmaceutical Group Product
Table 117. Yangtze River Pharmaceutical Group Recent Development
Table 118. Global Orexin Receptor Type 2 Sales Forecast by Regions (2021-2026) (K Pcs)
Table 119. Global Orexin Receptor Type 2 Sales Market Share Forecast by Regions (2021-2026)
Table 120. Global Orexin Receptor Type 2 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 121. Global Orexin Receptor Type 2 Revenue Market Share Forecast by Regions (2021-2026)
Table 122. North America: Orexin Receptor Type 2 Sales Forecast by Country (2021-2026) (K Pcs)
Table 123. North America: Orexin Receptor Type 2 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 124. Europe: Orexin Receptor Type 2 Sales Forecast by Country (2021-2026) (K Pcs)
Table 125. Europe: Orexin Receptor Type 2 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Asia Pacific: Orexin Receptor Type 2 Sales Forecast by Region (2021-2026) (K Pcs)
Table 127. Asia Pacific: Orexin Receptor Type 2 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 128. Latin America: Orexin Receptor Type 2 Sales Forecast by Country (2021-2026) (K Pcs)
Table 129. Latin America: Orexin Receptor Type 2 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Middle East and Africa: Orexin Receptor Type 2 Sales Forecast by Country (2021-2026) (K Pcs)
Table 131. Middle East and Africa: Orexin Receptor Type 2 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 133. Key Challenges
Table 134. Market Risks
Table 135. Main Points Interviewed from Key Orexin Receptor Type 2 Players
Table 136. Orexin Receptor Type 2 Customers List
Table 137. Orexin Receptor Type 2 Distributors List
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Orexin Receptor Type 2 Product Picture
Figure 2. Global Orexin Receptor Type 2 Sales Market Share by Type in 2020 & 2026
Figure 3. HTL-6641 Product Picture
Figure 4. MK-8133 Product Picture
Figure 5. Lemborexant Product Picture
Figure 6. OPN-021 Product Picture
Figure 7. YNT-185 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Orexin Receptor Type 2 Sales Market Share by Application in 2020 & 2026
Figure 10. Insomnia
Figure 11. Narcolepsy
Figure 12. Sleep Disorders
Figure 13. Major Depressive Disorder
Figure 14. Orexin Receptor Type 2 Report Years Considered
Figure 15. Global Orexin Receptor Type 2 Market Size 2015-2026 (US$ Million)
Figure 16. Global Orexin Receptor Type 2 Sales 2015-2026 (K Pcs)
Figure 17. Global Orexin Receptor Type 2 Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Orexin Receptor Type 2 Sales Market Share by Region (2015-2020)
Figure 19. Global Orexin Receptor Type 2 Sales Market Share by Region in 2019
Figure 20. Global Orexin Receptor Type 2 Revenue Market Share by Region (2015-2020)
Figure 21. Global Orexin Receptor Type 2 Revenue Market Share by Region in 2019
Figure 22. Global Orexin Receptor Type 2 Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Orexin Receptor Type 2 Revenue in 2019
Figure 24. Orexin Receptor Type 2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Orexin Receptor Type 2 Sales Market Share by Type (2015-2020)
Figure 26. Global Orexin Receptor Type 2 Sales Market Share by Type in 2019
Figure 27. Global Orexin Receptor Type 2 Revenue Market Share by Type (2015-2020)
Figure 28. Global Orexin Receptor Type 2 Revenue Market Share by Type in 2019
Figure 29. Global Orexin Receptor Type 2 Market Share by Price Range (2015-2020)
Figure 30. Global Orexin Receptor Type 2 Sales Market Share by Application (2015-2020)
Figure 31. Global Orexin Receptor Type 2 Sales Market Share by Application in 2019
Figure 32. Global Orexin Receptor Type 2 Revenue Market Share by Application (2015-2020)
Figure 33. Global Orexin Receptor Type 2 Revenue Market Share by Application in 2019
Figure 34. North America Orexin Receptor Type 2 Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America Orexin Receptor Type 2 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Orexin Receptor Type 2 Sales Market Share by Country in 2019
Figure 37. North America Orexin Receptor Type 2 Revenue Market Share by Country in 2019
Figure 38. U.S. Orexin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. Orexin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Orexin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada Orexin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Orexin Receptor Type 2 Market Share by Type in 2019
Figure 43. North America Orexin Receptor Type 2 Market Share by Application in 2019
Figure 44. Europe Orexin Receptor Type 2 Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe Orexin Receptor Type 2 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Orexin Receptor Type 2 Sales Market Share by Country in 2019
Figure 47. Europe Orexin Receptor Type 2 Revenue Market Share by Country in 2019
Figure 48. Germany Orexin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany Orexin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Orexin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France Orexin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Orexin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. Orexin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Orexin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy Orexin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Orexin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia Orexin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Orexin Receptor Type 2 Market Share by Type in 2019
Figure 59. Europe Orexin Receptor Type 2 Market Share by Application in 2019
Figure 60. Asia Pacific Orexin Receptor Type 2 Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific Orexin Receptor Type 2 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Orexin Receptor Type 2 Sales Market Share by Region in 2019
Figure 63. Asia Pacific Orexin Receptor Type 2 Revenue Market Share by Region in 2019
Figure 64. China Orexin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China Orexin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Orexin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Orexin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Orexin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea Orexin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Orexin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India Orexin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Orexin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia Orexin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Orexin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan Orexin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Orexin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia Orexin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Orexin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand Orexin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Orexin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia Orexin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Orexin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines Orexin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Orexin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam Orexin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Orexin Receptor Type 2 Market Share by Type in 2019
Figure 87. Asia Pacific Orexin Receptor Type 2 Market Share by Application in 2019
Figure 88. Latin America Orexin Receptor Type 2 Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America Orexin Receptor Type 2 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Orexin Receptor Type 2 Sales Market Share by Country in 2019
Figure 91. Latin America Orexin Receptor Type 2 Revenue Market Share by Country in 2019
Figure 92. Mexico Orexin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico Orexin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Orexin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil Orexin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Orexin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina Orexin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Orexin Receptor Type 2 Market Share by Type in 2019
Figure 99. Latin America Orexin Receptor Type 2 Market Share by Application in 2019
Figure 100. Middle East and Africa Orexin Receptor Type 2 Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa Orexin Receptor Type 2 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Orexin Receptor Type 2 Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Orexin Receptor Type 2 Revenue Market Share by Country in 2019
Figure 104. Turkey Orexin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey Orexin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Orexin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia Orexin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Orexin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E Orexin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Orexin Receptor Type 2 Market Share by Type in 2019
Figure 111. Middle East and Africa Orexin Receptor Type 2 Market Share by Application in 2019
Figure 112. North America Orexin Receptor Type 2 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. North America Orexin Receptor Type 2 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Orexin Receptor Type 2 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Europe Orexin Receptor Type 2 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Orexin Receptor Type 2 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Asia Pacific Orexin Receptor Type 2 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Orexin Receptor Type 2 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Latin America Orexin Receptor Type 2 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Orexin Receptor Type 2 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Middle East and Africa Orexin Receptor Type 2 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed

---